AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Spinal Cord Injury Model Systems (SCIMS) - Education Module

RecruitingNAAges 18 Years - 70 YearsAllUniversity of Miami
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The purpose of this study is to find out if receiving education regarding increased risks of cardiometabolic disease helps subjects understand these risks and how these risks participants' health.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Men and Women with SCI/D aged 18-70 years. 2. Neurologically complete and incomplete American Spinal Injury Association (ASIA) Impairment scale (AIS) A-D spinal cord levels C5 and below. 3. Enrolled no later than 4 months following discharge from initial rehabilitation from SCI. Exclusion Criteria: 1. Pregnancy determined by urine testing in sexually active females. 2. Cognitive impairment that compromises the legitimacy of consent. 3. Grade 3-4 pressure injury at the time of study entry. 4. Prisoners
๐Ÿ’Š

What it tests

  • PVA Consumer Guide
  • WebMD
๐Ÿ“

Where

3 sites
MedStar National Rehabilitation Network
Washington D.C., United States
University of Miami - Miami Project to Cure Paralysis
Miami, United States
Baylor Scott & White Institute for Research
Dallas, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy